<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/10/1110" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/10/1110/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/10/1110/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_1110"><akn:num>1110</akn:num><akn:heading>System for tracking and recording vaccine information; anthrax vaccine immunization program</akn:heading><akn:content><akn:p>§ 1110. System for tracking and recording vaccine information; anthrax vaccine immunization program(a) Overall System to Track and Record Vaccine Information.—(1) The Secretary of Defense, in consultation with the Director of the Defense Health Agency and in coordination with the Secretaries of the military departments, shall establish a system to track and record the following information:(A) Each vaccine administered by a health care provider of the Department of Defense to a member of an armed force under the jurisdiction of the Secretary of a military department.

(B) Any adverse reaction of the member related to such vaccine.

(C) Each refusal by such a member of any vaccine that is being so administered, including vaccines licensed by the Food and Drug Administration under section 351 of the Public Health Service Act (42 U.S.C. 262) and vaccines otherwise approved or authorized.

(D) Each refusal by such a member of a vaccine on the basis that the vaccine is being administered by a health care provider of the Department pursuant to an emergency use authorization granted by the Commissioner of Food and Drugs under section 564 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–3).

(E) Each refusal by such a member of an investigational new drug or a drug unapproved for its applied use that is being administered pursuant to a request or requirement of the Secretary of Defense and with respect to which the President has granted a waiver of the prior consent requirement pursuant to section 1107(f)(1) of this title.


(2) In carrying out paragraph (1), the Secretary of Defense shall ensure that—(A) any electronic health record maintained by the Secretary for a member of an armed force under the jurisdiction of the Secretary of a military department is updated with the information specified in such paragraph with respect to the member;

(B) any collection, storage, or use of such information is conducted through means involving such cyber protections as t</akn:p></akn:content><akn:subsection eId="subsec_1110_a"><akn:num>(a)</akn:num><akn:heading>Overall System to Track and Record Vaccine Information.—</akn:heading><akn:content><akn:p>(a)</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1110_b"><akn:num>(b)</akn:num><akn:heading>Procedures for Medical and Administrative Exemptions From Anthrax Vaccine Immunization Program.—</akn:heading><akn:content><akn:p>(b)</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_1110_c"><akn:num>(c)</akn:num><akn:heading>System for Monitoring Adverse Reactions to Anthrax Vaccine.—</akn:heading><akn:content><akn:p>(c)</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>